SPS
MED icon

Susquehanna Portfolio Strategies’s Medifast MED Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
+41,777
New +$482K 0.01% 684

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna Portfolio Strategies's MED Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Medifast (MED) in Q2 2026: 41,777 shares worth $443K. The stake represents 0.01% of the portfolio and ranks #684 among its holdings.

113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Susquehanna Portfolio Strategies held 41,777 shares of Medifast worth $443K as of Q2 2026.
  • Medifast was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Medifast made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #684 holding.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.